跳至主要内容
临床试验/ACTRN12621000036819
ACTRN12621000036819已完成4 期

Intervention with concentrated albumin for resuscitation of undifferentiated sepsis: A randomised controlled trial

Royal Brisbane and Women's Hospital0 个研究点目标入组 463 人开始时间: 2021年1月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
463

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult Emergency Department patients. >=18 years of age with:
  • 1a)Systolic blood pressure (SBP) <90mmHg within 8 hours of triage OR
  • 1b) Lactate < 4 mmol/L
  • 2)Proven or presumed infection. Patients with presumed infection will be those where the treating senior treating emergency physician deems infection the most likely cause for the patient presentation

排除标准

  • 1)Jehovah’s Witness
  • 2)Known adverse reaction to albumin administration
  • 3)Terminal state - death seems imminent and inevitable
  • 4)Pathological conditions in which albumin administration is clinically indicated (hepatic cirrhosis with ascites, intestinal malabsorption syndrome, nephrotic syndrome)
  • 5)Acute congestive heart failure
  • 6)Acute head injury
  • 7)Inter-hospital transfer
  • 8)Prior enrolment in the trial within the past 90 days
  • Patients must be enrolled as soon as possible, and within one hour of meeting inclusion criteria.

研究者

相似试验

Comparing albumin and saline for treatment of... | 临床试验